Parecoxib In Post Surgery (Hemicolectomy) Pain

Pfizer

Status and phase

Terminated

Phase 3

Conditions

Colectomy

Treatments

Drug: Paracoxib

Study type

Interventional

Funder types

Industry

Identifiers

NCT00139607

A3481022

PARA-0505-079

Details and patient eligibility

About

This is a phase III, multicenter, open label, pilot to evaluate the analgesic efficacy and safety of parecoxib 40 mg IV in the treatment of the pain following hemicolectomy in an optimal management of the surgical patient

Full description

The study was terminated prematurely due to recruitment issues on 31 January 2006. Safety concerns did not lead to the decision to terminate this study.

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients hospitalised for resection of left/right colon;
preoperative health graded as ASA <3.

Exclusion criteria

patients with any type of metastatic cancer, particularly metastatic colon cancer;
patients with familial adenomatous polyps (sporadic adenomatous polyps are accepted);